Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zuzana Sninská"'
Autor:
Gert J. Ossenkoppele, Dubravka Sertić, Perttu Koskenvesa, L.F. Casado, Doris Lindoerfer, F. Di Raimondo, Andrzej Hellmann, Andrija Bogdanovic, Verena S. Hoffmann, Irena Preloznik Zupan, Daniela Zackova, Laimonas Griskevicius, Fausto Castagnetti, Karel Indrak, Sonja Burgstaller, Martin Höglund, Michele Baccarani, Andrey Zaritskey, Ruediger Hehlmann, Joelle Guilhot, Paul Costeas, Anna G. Turkina, Sandra Lejniece, Tomasz Sacha, Richard E. Clark, Joerg Hasford, Andreas Hochhaus, Susanne Saussele, Zuzana Sninská, Gabriele Schubert-Fritschle, Hele Everaus, Gianantonio Rosti, Bengt Simonsson
Publikováno v:
Leukemia, 31(3), 593-601. Nature Publishing Group
Hoffmann, V S, Baccarani, M, Hasford, J, Castagnetti, F, Di Raimondo, F, Casado, L F, Turkina, A, Zackova, D, Ossenkoppele, G, Zaritskey, A, Höglund, M, Simonsson, B, Indrak, K, Sninska, Z, Sacha, T, Clark, R, Bogdanovic, A, Hellmann, A, Griskevicius, L, Schubert-Fritschle, G, Sertic, D, Guilhot, J, Lejniece, S, Zupan, I, Burgstaller, S, Koskenvesa, P, Everaus, H, Costeas, P, Lindoerfer, D, Rosti, G, Saussele, S, Hochhaus, A & Hehlmann, R 2017, ' Treatment and outcome of 2904 CML patients from the EUTOS population-based registry ', Leukemia, vol. 31, no. 3, pp. 593-601 . https://doi.org/10.1038/leu.2016.246
Hoffmann, V S, Baccarani, M, Hasford, J, Castagnetti, F, Di Raimondo, F, Casado, L F, Turkina, A, Zackova, D, Ossenkoppele, G, Zaritskey, A, Höglund, M, Simonsson, B, Indrak, K, Sninska, Z, Sacha, T, Clark, R, Bogdanovic, A, Hellmann, A, Griskevicius, L, Schubert-Fritschle, G, Sertic, D, Guilhot, J, Lejniece, S, Zupan, I, Burgstaller, S, Koskenvesa, P, Everaus, H, Costeas, P, Lindoerfer, D, Rosti, G, Saussele, S, Hochhaus, A & Hehlmann, R 2017, ' Treatment and outcome of 2904 CML patients from the EUTOS population-based registry ', Leukemia, vol. 31, no. 3, pp. 593-601 . https://doi.org/10.1038/leu.2016.246
The European Treatment and Outcome Study (EUTOS) population-based registry includes data of all adult patients newly diagnosed with Philadelphia chromosome-positive and/or BCR-ABL1+ chronic myeloid leukemia (CML) in 20 predefined countries and region
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::187685d518aa1801d232adea9a7163ab
http://hdl.handle.net/20.500.11769/45823
http://hdl.handle.net/20.500.11769/45823
Autor:
G. Guidi, Michele Baccarani, F. Di Raimondo, Gabriele Schubert-Fritschle, Fausto Castagnetti, J-L Steegmann, Bengt Simonsson, A. Covelli, Tomasz Sacha, Irena Preloznik Zupan, Joelle Guilhot, Andrija Bogdanovic, Verena S. Hoffmann, Karel Indrak, Sandra Lejniece, Dubravka Sertić, Ruediger Hehlmann, Sonja Burgstaller, Richard E. Clark, Noortje Thielen, Perttu Koskenvesa, Joerg Hasford, Andrey Zaritskey, Zuzana Sninská, Laimonas Griskevicius, Hele Everaus, Paul Costeas, Anna G. Turkina, Jiří Mayer, Doris Lindoerfer, Andrzej Hellmann
Publikováno v:
Leukemia, 29(6), 1336-1343. Nature Publishing Group
Hoffmann, V S, Baccarani, M, Hasford, J, Lindoerfer, D, Burgstaller, S, Sertic, D, Costeas, P, Mayer, J, Indrak, K, Everaus, H, Koskenvesa, P, Guilhot, J, Schubert-Fritschle, G, Castagnetti, F, Di Raimondo, F, Lejniece, S, Griskevicius, L, Thielen, N, Sacha, T, Hellmann, A, Turkina, A G, Zaritskey, A, Bogdanovic, A, Sninska, Z, Zupan, I, Steegmann, J L, Simonsson, B, Clark, R E, Covelli, A, Guidi, G & Hehlmann, R 2015, ' The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries ', Leukemia, vol. 29, no. 6, pp. 1336-1343 . https://doi.org/10.1038/leu.2015.73
Hoffmann, V S, Baccarani, M, Hasford, J, Lindoerfer, D, Burgstaller, S, Sertic, D, Costeas, P, Mayer, J, Indrak, K, Everaus, H, Koskenvesa, P, Guilhot, J, Schubert-Fritschle, G, Castagnetti, F, Di Raimondo, F, Lejniece, S, Griskevicius, L, Thielen, N, Sacha, T, Hellmann, A, Turkina, A G, Zaritskey, A, Bogdanovic, A, Sninska, Z, Zupan, I, Steegmann, J L, Simonsson, B, Clark, R E, Covelli, A, Guidi, G & Hehlmann, R 2015, ' The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries ', Leukemia, vol. 29, no. 6, pp. 1336-1343 . https://doi.org/10.1038/leu.2015.73
This population-based registry was designed to provide robust and updated information on the characteristics and the epidemiology of chronic myeloid leukemia (CML). All cases of newly diagnosed Philadelphia positive, BCR-ABL1+ CML that occurred in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80316d3089de0a8c410f7721165ef2a4
https://ruj.uj.edu.pl/xmlui/handle/item/106928
https://ruj.uj.edu.pl/xmlui/handle/item/106928
Autor:
Ludmila Demitrovicova, Jana Lesko-Andrascikova, Adriana Kafková, Zuzana Sninská, Eva Mikuskova, Martin Mistrik, Tereza Nečasová, Stanislav Palasthy, Katarina Slezakova, Juraj Chudej, Eva Koritakova, Imrich Markuljak, Natalia Stecova, Elena Tóthová
Publikováno v:
ResearcherID
Introduction: With the onset of tyrosine kinase inhibitors (TKI) to treat patients with CML, the number of patients and overall survival increased and quality of life significantly improved. The basic principle of therapy was also changed, according
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb741c467c20df0c93539a7c8f0a9f06
https://doi.org/10.1182/blood.v128.22.3087.3087
https://doi.org/10.1182/blood.v128.22.3087.3087
Autor:
Dubravka Sertić, Noortje Thielen, Richard E. Clark, Zuzana Sninská, Bengt Simonsson, Gabriele Schubert-Fritschle, Michele Baccarani, Hele Everaus, Francesco Di Raimondo, Andrija Bogdanovic, Doris Lindoerfer, Sonja Burgstaller, Karel Indrak, Joerg Hasford, Joelle Guilhot, Felipe Casado, Andrzej Hellmann, Perttu Koskenvesa, Andreas Hochhaus, Irena Preložnik Zupan, Ruediger Hehlmann, Paul Costeas, Anna G. Turkina, Andrey Zaritskey, Jiri Mayer, Laimonas Griskevicius, Susanne Saussele, Sandra Lejniece, Verena S. Hoffmann, Thomas Sacha, Fausto Castagnetti
Publikováno v:
Blood. 126:2780-2780
Introduction Clinical studies clearly show that treatment with tyrosine-kinase inhibitors (TKI) greatly improve the prognosis of patients with CML. Detailed treatment recommendations have since been deduced from clinical trial results by the European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97d8dd44cc641c4709f3516b976371c0
https://doi.org/10.1182/blood.v126.23.2780.2780
https://doi.org/10.1182/blood.v126.23.2780.2780